-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F1YlGloL43itF10NtjuFh1eX/9sJnZRRWSwcJ2YxNOdb3LQx8ie/HtM3YAge1A28 my7PyAwIj1DD4YH+QQ638g== 0001140361-10-011216.txt : 20100310 0001140361-10-011216.hdr.sgml : 20100310 20100310181059 ACCESSION NUMBER: 0001140361-10-011216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100303 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoenlein Malcolm CENTRAL INDEX KEY: 0001294517 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 10671763 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 doc1.xml FORM 4 X0303 4 2010-03-03 1 0001001316 MANHATTAN PHARMACEUTICALS INC MHAN 0001294517 Hoenlein Malcolm C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET, SUITE 1110 NEW YORK NY 10005 0 0 0 1 Former Director Common Stock 1191 D Stock Options 0.97 2014-09-27 Common Stock 80000 80000 D Stock Options 1.00 2015-01-11 Common Stock 11010 11010 D Stock Options 0.72 2017-01-30 Common Stock 50000 50000 D Stock Options 0.17 2018-03-25 Common Stock 75000 75000 D Stock Options 0.07 2010-03-03 4 A 0 250000 0 A 2015-03-02 Common Stock 250000 250000 D The option vested as to 26,667 shares on each of September 27, 2004 and September 27, 2005, and as to the remaining 26,666 shares on September 27, 2006. The option vested as to 3,670 shares on each of January 11, 2005, January 11, 2006 and January 11, 2007. The option vested as to 16,667 shares on each of January 30, 2007 and January 30, 2008, and as to the remaining 16,666 shares on January 30, 2009. The option vested as to 41,667 shares on March 25, 2008 and as to an additional 16,667 shares on March 25, 2009. The remaining 16,666 shares are scheduled to vest on March 25, 2010. On March 3, 2010, the reporting person was granted an option to purchase 250,000 shares of common stock of Manhattan Pharmaceuticals, Inc. (the "Company") under the 2003 Stock Option Plan. The reporting person left the Company's board of directors on March 8, 2010. The option vested in its entirety on the date of grant. /s/ Malcolm Hoenlein 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----